Dr. Marlise R Luskin, MD
Claim this profileDana Farber Cancer Institute
Area of expertise
Leukemia
Marlise R Luskin, MD has run 6 trials for Leukemia. Some of their research focus areas include:
Burkitt Lymphoma
Marlise R Luskin, MD has run 4 trials for Burkitt Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Dana Farber Cancer Institute
Brigham And Women's Hospital
Clinical Trials Marlise R Luskin, MD is currently running
Venetoclax + Chemotherapy
for Leukemia
This research study is studying a medication called Venetoclax and a chemotherapy regimen as a possible treatment for Acute Lymphoblastic Leukemia. The drugs involved in this study are: * Venetoclax * Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine
Recruiting
3 awards
Phase 1 & 2
ABL001 Combo Therapy
for Leukemia
This research study is evaluating a drug called ABL001 taken in combination with dasatinib (Sprycel®) and prednisone (a steroid) as a possible treatment for B-cell Acute Lymphoblastic Leukemia that is BCR-ABL positive (BCR-ABL+ B-ALL) or Chronic Myeloid Leukemia (CML) in lymphoid blast crisis. BCR-ABL+ B-ALL is also called Philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ ALL). It is expected that 40-65 people will take part in this research study. * ABL001 * Dasatinib (Sprycel®) * Prednisone * Blinatumomab
Recruiting
1 award
Phase 1
More about Marlise R Luskin, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Marlise R Luskin, MD has experience with
- Venetoclax
- Dexamethasone
- Inotuzumab Ozogamicin
- MBG453
- Ruxolitinib
- Standard Chemotherapy
Breakdown of trials Marlise R Luskin, MD has run
Leukemia
Burkitt Lymphoma
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marlise R Luskin, MD specialize in?
Marlise R Luskin, MD focuses on Leukemia and Burkitt Lymphoma. In particular, much of their work with Leukemia has involved CD19 positive patients, or patients who are BCR-ABL1 positive.
Is Marlise R Luskin, MD currently recruiting for clinical trials?
Yes, Marlise R Luskin, MD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Marlise R Luskin, MD has studied deeply?
Yes, Marlise R Luskin, MD has studied treatments such as Venetoclax, Dexamethasone, Inotuzumab Ozogamicin.
What is the best way to schedule an appointment with Marlise R Luskin, MD?
Apply for one of the trials that Marlise R Luskin, MD is conducting.
What is the office address of Marlise R Luskin, MD?
The office of Marlise R Luskin, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02115 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.